Categories AlphaGraphs, Earnings, Technology

Earnings: Highlights of International Business Machines (IBM) Q2 results

International Business Machines Corporation (NYSE: IBM) on Wednesday announced operating results for the second quarter of 2023, reporting a decline in adjusted earnings.

IBM Q2 2023 earnings infographic

Total revenues were $15.5 billion in the second quarter of 2023, which is broadly unchanged from the prior-year period. Meanwhile, adjusted earnings from continuing operations declined to $2.18 per share from $2.31 per share in the year-ago period. On an unadjusted basis, June-quarter net profit was $1.58 billion or $1.72 per share, compared to $1.39 billion or $1.53 per share in the corresponding period of 2022.

“We continue to respond to the needs of our clients who seek trusted, enterprise AI solutions, and we are particularly excited about the response to the recently launched watsonx AI platform. Finally, we remain confident in our revenue and free cash flow growth expectations for the full year,” said IBM’s CEO Arvind Krishna.

Prior Performance

  • IBM Q3 2022 earnings infographic
  • International Business Machines Q4 2022 earnings infographic

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Citigroup set to report Q4 2025 earnings. Here’s what to expect

Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the

Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon

Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top